Study Stopped
Trial terminated by Sponsor
Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of Persistent Symptoms in Patients With Celiac Disease on a GFD
1 other identifier
interventional
307
1 country
160
Brief Summary
To assess the efficacy and safety of larazotide acetate versus placebo for the relief of persistent symptoms in adult celiac disease patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started May 2019
Typical duration for phase_3
160 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2018
CompletedFirst Posted
Study publicly available on registry
June 26, 2018
CompletedStudy Start
First participant enrolled
May 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2022
CompletedJuly 26, 2022
August 1, 2021
3.1 years
June 14, 2018
July 22, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of subjects who are binary responders
Reduction in CeD PRO Abdominal Domain scores
12 weeks
Study Arms (3)
Larazotide 0.25 mg
ACTIVE COMPARATORLarazotide 0.25 mg capsules TID
Larazotide 0.50 mg
ACTIVE COMPARATORLarazotide 0.50 mg capsules TID
Placebo
PLACEBO COMPARATORMatching placebo capsules TID
Interventions
Synthetic 8-amino acid peptide formulated as enteric-coated beads in gelatin capsules
Eligibility Criteria
You may qualify if:
- Male and female adults diagnosed with celiac disease (positive celiac serology plus confirmed biopsy) for at least 6 months
- On a gluten-free diet for at least 6 months
- Experiencing symptoms (ie, abdominal pain, abdominal cramping, bloating, gas, diarrhea, loose stool, or nausea)
- Willing to maintain current gluten-free diet throughout participation in the study
You may not qualify if:
- Refractory celiac disease or severe complications of celiac disease
- Chronic active GI disease other than celiac disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (160)
Research Site
Saraland, Alabama, 36571, United States
Research Site
Scottsdale, Arizona, 85251, United States
Research Site
Tucson, Arizona, 85712, United States
Research Site
Tucson, Arizona, 85745, United States
Research Site
North Little Rock, Arkansas, 72117, United States
Research Site
Bellflower, California, 90706, United States
Research Site
Beverly Hills, California, 90211, United States
Research Site
Canoga Park, California, 91303, United States
Research Site
Corona, California, 92879, United States
Research Site
Garden Grove, California, 92845, United States
Research Site
Lancaster, California, 93534, United States
Research Site
Los Gatos, California, 95032, United States
Research Site
Northridge, California, 91324, United States
Research Site
Poway, California, 92064, United States
Research Site
Rialto, California, 92377, United States
Research Site
San Diego, California, 92013, United States
Research Site
San Diego, California, 92103, United States
Research Site
San Francisco, California, 94102, United States
Research Site
Walnut Creek, California, 94598, United States
Research Site
Bridgeport, Connecticut, 06606, United States
Research Site
Bristol, Connecticut, 06010, United States
Research Site
Hamden, Connecticut, 06518, United States
Research Site
Stamford, Connecticut, 06905, United States
Research Site
Boynton Beach, Florida, 33472, United States
Research Site
Clearwater, Florida, 33756, United States
Research Site
Inverness, Florida, 34452, United States
Research Site
Lakewood Rch, Florida, 34211, United States
Research Site
Miami, Florida, 33133, United States
Research Site
Orange Park, Florida, 32073, United States
Research Site
Orlando, Florida, 32803, United States
Research Site
Orlando, Florida, 32825, United States
Research Site
Port Orange, Florida, 32127, United States
Research Site
Atlanta, Georgia, 30328, United States
Research Site
Columbus, Georgia, 31904, United States
Research Site
Macon, Georgia, 31201, United States
Research Site
Stockbridge, Georgia, 30281, United States
Research Site
Stone Mountain, Georgia, 30083, United States
Research Site
Sugar Hill, Georgia, 30518, United States
Research Site
Boise, Idaho, 83706, United States
Research Site
Idaho Falls, Idaho, 83404, United States
Research Site
Arlington Heights, Illinois, 60005, United States
Research Site
Fairview Heights, Illinois, 62208, United States
Research Site
Melrose Park, Illinois, 60160, United States
Research Site
Morton, Illinois, 61550, United States
Research Site
Clive, Iowa, 50325, United States
Research Site
Iowa City, Iowa, 52242, United States
Research Site
West Des Moines, Iowa, 50266, United States
Research Site
Topeka, Kansas, 66606, United States
Research Site
Lexington, Kentucky, 40509, United States
Research Site
Lexington, Kentucky, 40536, United States
Research Site
Louisville, Kentucky, 40202, United States
Research Site
Crowley, Louisiana, 70526, United States
Research Site
Lafayette, Louisiana, 70503, United States
Research Site
Marrero, Louisiana, 70072, United States
Research Site
Metairie, Louisiana, 70006, United States
Research Site
New Orleans, Louisiana, 70115, United States
Research Site
New Orleans, Louisiana, 70125, United States
Research Site
Annapolis, Maryland, 21401, United States
Research Site
Baltimore, Maryland, 21208, United States
Research Site
Catonsville, Maryland, 21228, United States
Research Site
Columbia, Maryland, 21045, United States
Research Site
Hagerstown, Maryland, 21742, United States
Research Site
Boston, Massachusetts, 02114, United States
Research Site
Fall River, Massachusetts, 02723, United States
Research Site
Chesterfield, Michigan, 48047, United States
Research Site
Rochester, Michigan, 48307, United States
Research Site
Wyoming, Michigan, 49519, United States
Research Site
Jackson, Minnesota, 39216, United States
Research Site
Maplewood, Minnesota, 55117, United States
Research Site
Rochester, Minnesota, 55905, United States
Research Site
Petal, Mississippi, 39465, United States
Research Site
Jefferson City, Missouri, 65109, United States
Research Site
St Louis, Missouri, 63141, United States
Research Site
Omaha, Nebraska, 68114, United States
Research Site
Omaha, Nebraska, 68134, United States
Research Site
Las Vegas, Nevada, 89106, United States
Research Site
Las Vegas, Nevada, 89109, United States
Research Site
Las Vegas, Nevada, 89119, United States
Research Site
Las Vegas, Nevada, 89128, United States
Research Site
Reno, Nevada, 89511, United States
Research Site
Portsmouth, New Hampshire, 03801, United States
Research Site
Freehold, New Jersey, 07728, United States
Research Site
Ocean Township, New Jersey, 07712, United States
Research Site
Albuquerque, New Mexico, 87102, United States
Research Site
Great Neck, New York, 11023, United States
Research Site
Mineola, New York, 11501, United States
Research Site
New Windsor, New York, 12553, United States
Research Site
New York, New York, 10016, United States
Research Site
New York, New York, 10032, United States
Research Site
New York, New York, 11419, United States
Research Site
Poughkeepsie, New York, 12601, United States
Research Site
Williamsville, New York, 14221, United States
Research Site
Asheville, North Carolina, 28801, United States
Research Site
Charlotte, North Carolina, 28207, United States
Research Site
Concord, North Carolina, 28025, United States
Research Site
Greenville, North Carolina, 27834, United States
Research Site
Salisbury, North Carolina, 28144, United States
Research Site
Winston-Salem, North Carolina, 27103, United States
Research Site
Cincinnati, Ohio, 45215, United States
Research Site
Cincinnati, Ohio, 45219, United States
Research Site
Cleveland, Ohio, 44122, United States
Research Site
Columbus, Ohio, 04323, United States
Research Site
Columbus, Ohio, 43214, United States
Research Site
Dayton, Ohio, 45415, United States
Research Site
Dayton, Ohio, 45419, United States
Research Site
Mentor, Ohio, 44060, United States
Research Site
Poland, Ohio, 44514, United States
Research Site
Norman, Oklahoma, 73071, United States
Research Site
Oklahoma City, Oklahoma, 73112, United States
Research Site
Tulsa, Oklahoma, 74104, United States
Research Site
Happy Valley, Oregon, 97086, United States
Research Site
Medford, Oregon, 97504, United States
Research Site
Hershey, Pennsylvania, 17033, United States
Research Site
Philadelphia, Pennsylvania, 19107, United States
Research Site
Sayre, Pennsylvania, 18840, United States
Research Site
Scranton, Pennsylvania, 18508, United States
Research Site
Lincoln, Rhode Island, 02865, United States
Research Site
Warwick, Rhode Island, 02886, United States
Research Site
Mt. Pleasant, South Carolina, 29464, United States
Research Site
West Columbia, South Carolina, 29169, United States
Research Site
Sioux Falls, South Dakota, 57108, United States
Research Site
Chattanooga, Tennessee, 37421, United States
Research Site
Nashville, Tennessee, 37212, United States
Research Site
Austin, Texas, 77024, United States
Research Site
Austin, Texas, 78704, United States
Research Site
Austin, Texas, 78726, United States
Research Site
Austin, Texas, 78745, United States
Research Site
Austin, Texas, 78757, United States
Research Site
Cypress, Texas, 77429, United States
Research Site
Dallas, Texas, 75224, United States
Research Site
DeSoto, Texas, 75115, United States
Research Site
Garland, Texas, 75044, United States
Research Site
Harlingen, Texas, 78550, United States
Research Site
Houston, Texas, 77025, United States
Research Site
Houston, Texas, 77058, United States
Research Site
Houston, Texas, 77084, United States
Research Site
McAllen, Texas, 78503, United States
Research Site
San Antonio, Texas, 78215, United States
Research Site
San Antonio, Texas, 78229, United States
Research Site
Sugar Land, Texas, 77476, United States
Research Site
Sugar Land, Texas, 77479, United States
Research Site
Victoria, Texas, 77904, United States
Research Site
Ogden, Utah, 84403, United States
Research Site
Ogden, Utah, 84405, United States
Research Site
Salt Lake City, Utah, 84124, United States
Research Site
Sandy City, Utah, 84092, United States
Research Site
St. George, Utah, 84790, United States
Research Site
Chesapeake, Virginia, 23320, United States
Research Site
Fairfax, Virginia, 22031, United States
Research Site
Gainesville, Virginia, 20155, United States
Research Site
Lansdowne Town Center, Virginia, 20176, United States
Research Site
Lynchburg, Virginia, 24502, United States
Research Site
Norfolk, Virginia, 23507, United States
Research Site
Bellevue, Washington, 98004, United States
Research Site
Bellevue, Washington, 98007, United States
Research Site
Spokane, Washington, 99202, United States
Research Site
Spokane, Washington, 99204, United States
Research Site
Tacoma, Washington, 98405, United States
Research Site
Vancouver, Washington, 98664, United States
Research Site
Wauwatosa, Wisconsin, 53226, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Double-blind
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2018
First Posted
June 26, 2018
Study Start
May 29, 2019
Primary Completion
July 21, 2022
Study Completion
July 21, 2022
Last Updated
July 26, 2022
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share